Daniel Arias Analyst PerformanceManaging Director at Stifel NicolausDaniel Arias is a stock analyst at Stifel Nicolaus focused in the medical sector, covering 17 publicly traded companies. Over the past year, Daniel Arias has issued 25 stock ratings, including buy and hold recommendations. While full access to Daniel Arias' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Daniel Arias' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings41 Last 9 YearsBuy Recommendations64.86% 24 Buy RatingsCompanies Covered17 Unique Companies Ratings Distribution37RatingsDistribution of strong buy, buy, hold, and sell ratings by Daniel Arias.RatingPercentageCount Strong Buy0.0%0 ratings Buy64.9%24 ratings Hold35.1%13 ratings Sell0.0%0 ratingsOut of 37 total stock ratings issued by Daniel Arias at Stifel Nicolaus, the majority (64.9%) have been Buy recommendations, followed by 35.1% Hold.Best & Worst CallsBest Call0000.0%GHFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%MXCTMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ64.7% of companies on NASDAQ11 companiesNYSE35.3% of companies on NYSE6 companiesDaniel Arias, an analyst at Stifel Nicolaus, currently covers 17 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical14 companies82.4%Manufacturing1 company5.9%Computer and Technology1 company5.9%Services1 company5.9%Daniel Arias of Stifel Nicolaus specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE7 companies41.2%MEDICAL SERVICES3 companies17.6%MED INSTRUMENTS2 companies11.8%MEDICAL INFO SYS2 companies11.8%LAB ANALYTICAL INSTRUMENTS1 company5.9%INSTRU - SCIENTFC1 company5.9%SERVICES – HEALTH1 company5.9% About Daniel AriasDan Arias joined Stifel in June 2019. He is a Managing Director in the Healthcare sector, covering Life Sciences and Diagnostics. Before joining Stifel, Dan previously covered Life Sciences and Diagnostics at Citigroup and UBS. He previously worked in the research microbiology lab at Wyeth Pharmaceuticals. Dan is a graduate of Mary Washington College and Rutgers Business School.Follow on LinkedIn Daniel Arias' Ratings History at Stifel Nicolaus Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMTDMettler-Toledo International5/18/2026Lower Price Target$1,062.40$1,400.00Buy$0.0000.00% ROIALMRAlamar Biosciences5/12/2026Initiated Coverage$23.88$28.00Buy$0.0000.00% ROIBRKRBruker5/8/2026Set Price Target$42.82$45.00$0.0000.00% ROIRVTYRevvity5/6/2026Lower Price Target$93.65$100.00Hold$0.0000.00% ROITMOThermo Fisher Scientific4/24/2026Lower Price Target$466.93$600.00Buy$0.0000.00% ROICDXSCodexis3/12/2026Set Price Target$1.72$5.00$0.0000.00% ROITXG10x Genomics3/2/2026Boost Price Target$23.05$25.00Buy$0.0000.00% ROITEMTempus AI2/25/2026Set Price Target$54.17$60.00$0.0000.00% ROIGHGuardant Health2/20/2026Boost Price Target$106.38$130.00Buy$0.0000.00% ROITXG10x Genomics2/13/2026Boost Price Target$17.51$20.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. QGENQiagen2/6/2026Set Price Target$51.22$50.00Hold$0.0000.00% ROITECHBio-Techne2/5/2026Set Price Target$67.23$65.00Hold$0.0000.00% ROIILMNIllumina1/20/2026Boost Price Target$141.65$155.00Buy$0.0000.00% ROITMOThermo Fisher Scientific1/9/2026Boost Price Target$606.16$700.00Buy$0.0000.00% ROIGHGuardant Health1/9/2026Boost Price Target$108.74$120.00Buy$0.0000.00% ROIBLLNBilliontoone12/1/2025Initiated Coverage$130.18$145.00Buy$0.0000.00% ROIEXASExact Sciences11/28/2025Reiterated Rating$101.35$105.00Hold$0.0000.00% ROIMTDMettler-Toledo International11/10/2025Boost Price Target$1,438.69$1,600.00Buy$0.0000.00% ROIEXASExact Sciences11/4/2025Boost Price Target$66.98$80.00Buy$0.0000.00% ROIGHGuardant Health9/25/2025Set Price Target$62.81$73.00$0.0000.00% ROIGHGuardant Health9/25/2025Boost Price Target$60.28$70.00Buy$0.0000.00% ROIBRKRBruker8/5/2025Set Price Target$34.72$40.00Hold$0.0000.00% ROIAVTRAvantor8/4/2025Set Price Target$11.41$12.00Hold$0.0000.00% ROIRVTYRevvity7/29/2025Lower Price Target$95.66$110.00Hold$0.0000.00% ROIBRKRBruker5/8/2025Lower Price Target$40.95$48.00Hold$00.0000.00% ROITECHBio-Techne5/8/2025Lower Price Target$48.76$60.00Hold$00.0000.00% ROIGHGuardant Health5/1/2025Boost Price Target$48.06$60.00Buy$00.0000.00% ROIAVTRAvantor4/28/2025Downgrade$12.93$14.00Hold$0.0000.00% ROITMOThermo Fisher Scientific4/24/2025Lower Price Target$422.94$620.00Buy$000.0000.00% ROIDHRDanaher3/14/2025Upgrade$203.96$260.00Buy$000.0000.00% ROIMXCTMaxCyte3/12/2025Lower Price Target$3.47$9.00Buy$0.0000.00% ROIGHGuardant Health2/21/2025Boost Price Target$45.85$53.00Buy$000.0000.00% ROIBRKRBruker2/14/2025Lower Price Target$50.29$57.00Hold$00.0000.00% ROITXG10x Genomics2/13/2025Lower Price Target$11.52$18.00Buy$00.0000.00% ROIAVTRAvantor2/10/2025Lower Price Target$19.15$26.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
